Cargando…
Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice
X-linked nephrogenic diabetes insipidus (X-NDI) is a disease caused by inactivating mutations of the vasopressin (AVP) type 2 receptor (V2R) gene. Loss of V2R function prevents plasma membrane expression of the AQP2 water channel in the kidney collecting duct cells and impairs the kidney concentrati...
Autores principales: | Procino, Giuseppe, Milano, Serena, Carmosino, Monica, Barbieri, Claudia, Nicoletti, Maria C, H. Li, Jian, Wess, Jürgen, Svelto, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080339/ https://www.ncbi.nlm.nih.gov/pubmed/24522493 http://dx.doi.org/10.1038/ki.2014.10 |
Ejemplares similares
-
Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update
por: Milano, Serena, et al.
Publicado: (2017) -
β3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus
por: Milano, Serena, et al.
Publicado: (2023) -
A novel therapeutic effect of statins on nephrogenic diabetes insipidus
por: Bonfrate, Leonilde, et al.
Publicado: (2015) -
β(3) adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function
por: Procino, Giuseppe, et al.
Publicado: (2016) -
Treatment of Nephrogenic Diabetes Insipidus Patients With cGMP-Stimulating Drugs Does Not Mitigate Polyuria or Increase Urinary Concentrating Ability
por: Hinrichs, Gitte R., et al.
Publicado: (2020)